Miracle Elixirs

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.

Written byBob Grant
| 3 min read
curing cancer the scientist

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Above: Modified from © ISTOCK.COM, DrAfter123

Cancer has bedeviled humankind since long before scientists even had a word to describe the dread disease. It is therefore understandable that our ears long to hear those magic words that will signal an end to our multigenerational nightmare: “Cancer is cured.” But this shared craving has periodically clouded our judgment, leading us to replace reason and evidence with hope and excitement.

Earlier this year, for example, an Israeli biotech company told The Jerusalem Post, “We believe we will offer in a year’s time a complete cure for cancer.” This would be a bold statement even for a treatment that was on the precipice of regulatory approval. But the approach trumpeted by the company, Ness Ziona–based Accelerated Evolution Biotechnologies Ltd. (AEBi), hasn’t even started clinical trials. As a matter of fact, there doesn’t seem to be much, if anything, published in the scientific literature ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

The Scientist April 2019 Issue
April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series